|
市場調査レポート
商品コード
1133250
白血病治療薬の世界市場:治療タイプ別、白血病のタイプ別、分子タイプ別 - 地域別展望、競合戦略、セグメント別予測(~2030年)Leukemia Therapeutics Market- By Treatment Type, By Type of Leukemia, By Molecule Type - Regional Outlook, Competitive Strategies, and Segment Forecasts to 2030 |
||||||
白血病治療薬の世界市場:治療タイプ別、白血病のタイプ別、分子タイプ別 - 地域別展望、競合戦略、セグメント別予測(~2030年) |
出版日: 2022年10月10日
発行: SPER Market Research Pvt. Ltd.
ページ情報: 英文 208 Pages
納期: 即日から翌営業日
|
世界の白血病治療薬の市場規模は、2030年までに359億6,000万米ドルに達し、CAGRで11.3%の成長が予測されています。
白血病に苦しむ人々の数が増加しているため、血液がん検査の分野における技術の改善やブレークスルーが、世界の白血病治療薬市場を牽引しています。さらに、予防医療の重要性に関する人々の意識が高まっていることも、予測期間中の市場を牽引すると予想されます。
当レポートでは、世界の白血病治療薬市場について調査し、市場力学、市場変数と見通し、治療タイプ・白血病のタイプ・分子タイプ・地域別分析、企業プロファイル等に関する情報を提供しています。
According to SPER Market Research, the Global Leukemia Therapeutics Market is estimated to reach USD 35.96 billion by 2030 with a CAGR of 11.3%.
Leukemia is a type of blood cancer that affects the bone marrow and lymphatic system. It affects leucocytes, or white blood cells, as the name implies. The DNA of leucocytes is broken in this type of cancer, causing them to proliferate and divide uncontrollably. These cells continue to develop and accumulate, preventing healthy white blood cells from forming and functioning.
Leukemia can be acute or chronic, affecting both red blood cells and platelets. Fever, night sweats, weight loss, an enlarged liver, frequent infections, and swollen lymph nodes are all common symptoms of leukemia. Some of the numerous kinds of leukemia are acute myeloid leukemia, acute lymphoblastic leukemia, chronic myeloid leukemia, and chronic lymphocytic leukemia. Acute myeloid leukemia, also known as acute myelogenous leukemia, is most common in adults.
Because of the increased number of people suffering from leukemia, technical improvements and breakthroughs in the field of blood cancer testing are driving the Global Leukemia Therapeutics Market. Furthermore, rising public awareness about the importance of preventive healthcare is likely to drive the market throughout the forecast period. Government initiatives and policies encouraging cancer awareness are expected to drive market expansion until 2026.
Impact of COVID-19 on the Global Leukemia Therapeutics Market
The risk of infection is low in treating Leukemia during COVID-19 times. Although the mortality rate maybe be higher in patients with leukemia and COVID-19. Furthermore, according to the study "Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicentre Study During the COVID-19 Outbreak," published in Cancer Discovery in June 2021, the risk of severe COVID-19 infection was found to be higher, at around 57 percent, among patients with blood cancers.
Scope of the Report:
Report Metric Details
Market size available for years 2019-2030
Base year considered 2021
Forecast period 2022-2030
Segments covered By Treatment Type, By Type of Leukemia, By Molecule Type
Geographies covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Covered AbbVie Inc., Amgen Inc., Astellas Pharma Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Eli Lilly and Company Ltd., Gilead Sciences Inc. ICell Gene therapeutics, Merck & Company Inc., Novartis AG, Otsuka Holdings Company Ltd., Pfizer Inc., Roche HoldingAG, Stemline Therapeutics Inc., Takeda Pharmaceutical Company Ltd.
Global Leukemia Therapeutics Market, By Treatment Type:
Based on the Treatment Type, Global Leukemia Therapeutics Market is segmented as; Chemotherapy, Immunotherapy, Targeted Therapy, and Other Treatments
Global Leukemia Therapeutics Market, By Type of Leukemia:
Based on the Type of Leukemia, Global Leukemia Therapeutics Market is segmented as; Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, and Other Type of Leukemias.
Global Leukemia Therapeutics Market, By Molecule Type:
Based on the Molecule Type, Global Leukemia Therapeutics Market is segmented as; Small Molecules and Biologics.
Global Leukemia Therapeutics Market, By Region:
The Asia Pacific emerged as the leading region in the Global Leukemia Therapeutics Market with the maximum market share in 2021.